DDX53 and neoplasm: When mice were challenged with an increasing dose of CT26/HER2 cells (5 × 103, 5 × 104, 5 × 105 and 1 × 106 cells per mouse), they exhibited a tumor growth pattern that occurred in a tumor cell challenge dose-dependent manner (Figure 1A).